Magnesium Sulfate and Neuroendocrine Hormone

• Status: Recruiting
• Trial end date: 2021-12-15
• Target enrollment: 0
• Participant gender: Female

Summary

Total knee arthroplasty is a procedure that relieves pain in patients with severe symptomatic osteoarthritis, but it can be associated with postoperative pain, which hinders recovery. In the previous study, we reported evidence of increased pain in patients undergoing staged total knee arthroplasty, in whom the second operated knee had greater sensitivity (tertiary hyperalgesia) as a result of the surgical injury to the first operated knee.

Magnesium sulfate is an effective analgesic adjuvant for postoperative pain. Its analgesic property seems to be associated with the regulation of calcium influx into the cells, or antagonism of N-methyl-D-aspartate receptors in the central nervous system. Additionally, magnesium is known to have an anti-inflammatory effect. Inflammatory state may accompany with pain via peripheral or central sensitization.

Recently, we reported that magnesium sulfate effectively attenuates not only postoperative pain but also increased pain intensity without serious adverse effects in the bilateral staged total knee arthroplasty. However, the exact mechanism regarding these effects of magnesium sulfate remains unclear.

In the present study, we will investigate the analgesic mechanism of magnesium sulfate via analysis of endocrine neurosteroid levels in patients undergoing bilateral staged total knee arthroplasty.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: Seoul National University Bundang Hospital
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Patients who undergo staged bilateral total knee arthroplasty

• Spinal anesthesia

• American Society of Anesthesiologists physical status 1 and 2

Exclusion Criteria:

• Patients who undergo unilateral total knee arthroplasty

• General anesthesia

• Musculoskeletal disease

• Hypermagnesemia

• Atrioventricular block

• Previous history of administration of calcium channel blockers